Services

Global Product Development Services ] Trials Management Services ] Dedicated Clinical Operations Centers ] Local Country Clinical Trial Environments ] Early Development Services ] Drug Safety Management ] Electronic Regulatory Submissions ]

PRA offers a broad array of services that encompass the entire spectrum of clinical development, from filing of Investigational New Drug (IND) and similar regulatory applications to product registration and post-marketing studies on a global basis. Core services include:

  • Drug development and regulatory strategy plans
  • Phase I (first-time-in-man) clinical trials
  • Phase II through IV multi-center (international) clinical trials
  • Development and analysis of integrated global clinical databases
  • Preparation and submission of regulatory filings in North America and Europe
  • Long-term drug safety programs

Back up to top of page!

Page last updated: 30 January 2008

 
Your use of the information on this site is subject to the terms of our Legal Notice. Please also see our Privacy Policy, and Safe Harbor Privacy Policy. This site is published by PRA International, Inc. which is solely responsible for its contents. This information is intended for use by our customers, patients and healthcare professionals.